MOH · Company research
Molina Healthcare, Inc. (MOH): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
28records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| UnitedHealth's Q3 Margins Improve, But Membership Falls: Time to Buy? | UnitedHealth Group reported Q3 adjusted earnings of $4.69 per share, beating estimates by 13.9% with a 60.6% year-over-year increase. The company raised its 2026 EPS outlook to at least $20.50, driven by improved margins and lower medical costs. However, membership declined to 48.3 million from 50.1 million, raising questions about long-term sustainability. Optum also showed strong recovery with margins expanding to 5.6%. The stock carries a Zacks Rank #2 (Buy) rating with valuation below historical medians. | View source ↗ | Zacks Investment Research | Oct 16, 2026 | bullish | 0.333 | 1 |
| Can Molina Healthcare Overcome Lower Premiums and Higher MCR in Q3? | Molina Healthcare is projected to report a 60.9% earnings decline in Q3 2026 with revenues falling 4.8%. The company faces multiple headwinds including a 12.7% membership decline (63% drop in Marketplace enrollment), rising medical care ratio to 93%, and falling premium revenues and investment income. The stock has a negative Earnings ESP of -3.30% and Zacks Rank #4 (Sell), making an earnings beat unlikely. | View source ↗ | Zacks Investment Research | Oct 16, 2026 | bullish | 0.5 | 1 |
| Oscar Health vs. Molina: Which Healthcare Stock Is a Better Buy? | Oscar Health (OSCR) is positioned as the stronger investment compared to Molina Healthcare (MOH), driven by robust 46% membership growth, 70% revenue increase, a 20% revenue CAGR target through 2027, and a lower valuation multiple. Molina faces headwinds from rising medical costs, enrollment challenges, and portfolio restructuring, with a projected 2027 exit from its MAPD business and $1 billion marketplace premium reduction. | View source ↗ | Zacks Investment Research | Oct 16, 2026 | neutral | 0 | 1 |
| Molina Healthcare Inc (MOH) Stock Forecasts - Yahoo Finance | Molina Healthcare Inc (MOH) Stock Forecasts Yahoo Finance | View source ↗ | Yahoo Finance | Oct 14, 2026 | neutral | 0 | 0.6 |
| Analysts Estimate Molina (MOH) to Report a Decline in Earnings: What to Look Out for | Molina Healthcare is expected to report a significant year-over-year earnings decline of 60.9% to $0.72 per share for Q3 2026, with revenues down 4.8% to $10.93 billion. The stock carries a Zacks Rank #4 (Sell) with a negative Earnings ESP of -3.30%, making it unlikely to beat consensus estimates. While the company has beaten estimates in 2 of the last 4 quarters, current analyst sentiment has turned bearish with recent estimate revisions. | View source ↗ | Zacks Investment Research | Oct 14, 2026 | bearish | -1 | 1 |
| Analysts Estimate Molina (MOH) to Report a Decline in Earnings: What to Look Out for | Molina Healthcare is expected to report a significant year-over-year earnings decline of 60.9% to $0.72 per share for Q3 2026, with revenues down 4.8% to $10.93 billion. The stock carries a Zacks Rank #4 (Sell) with a negative Earnings ESP of -3.30%, making it unlikely to beat consensus estimates. While the company has beaten estimates in 2 of the last 4 quarters, current analyst sentiment has turned bearish with recent estimate revisions. | View source ↗ | Zacks Investment Research | Oct 14, 2026 | bearish | -1 | 1 |
| Molina Healthcare: Paying 21x For A Recovery That Hasn't Happened Yet - Seeking Alpha | Molina Healthcare: Paying 21x For A Recovery That Hasn't Happened Yet Seeking Alpha | View source ↗ | Seeking Alpha | Oct 14, 2026 | neutral | 0 | 0.6 |
| Centene vs. Molina: Which Managed Care Stock Has More Upside? | Centene (CNC) and Molina Healthcare (MOH) are compared as major players in U.S. managed care with significant Medicaid exposure. Centene benefits from diversified operations across Medicaid, Medicare, and Marketplace plans, improving margins, and strong financial position with lower leverage. Molina faces near-term profitability pressures from reimbursement challenges and Marketplace headwinds, though its expanding Medicaid contracts and Medicare Duals strategy offer long-term growth. Analysts favor Centene for near-term upside based on stronger earnings estimates, valuation, and recent stock performance. | View source ↗ | Zacks Investment Research | Oct 12, 2026 | bullish | 0.5 | 1 |
| Molina Healthcare (MOH) Stock May Look Reasonable On Its Sales Base - Simply Wall Street | Molina Healthcare (MOH) Stock May Look Reasonable On Its Sales Base Simply Wall Street | View source ↗ | Simply Wall Street | Oct 11, 2026 | neutral | 0 | 0.6 |
| MOH Dec 2026 230.000 put (MOH261218P00230000) Interactive Stock Chart - Yahoo! Finance Canada | MOH Dec 2026 230.000 put (MOH261218P00230000) Interactive Stock Chart Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 11, 2026 | neutral | 0 | 0.6 |
| Molina Healthcare Inc (MOH) Stock Forecasts - Yahoo! Finance Canada | Molina Healthcare Inc (MOH) Stock Forecasts Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 10, 2026 | neutral | 0 | 0.6 |
| MOH Dec 2026 150.000 put (MOH261218P00150000) Stock Price, News, Quote & History - Yahoo! Finance Canada | MOH Dec 2026 150.000 put (MOH261218P00150000) Stock Price, News, Quote & History Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 9, 2026 | neutral | 0 | 0.6 |
| Molina Healthcare Inc (MOH) Stock forecasts - Yahoo Finance UK | Molina Healthcare Inc (MOH) Stock forecasts Yahoo Finance UK | View source ↗ | Yahoo Finance UK | Oct 9, 2026 | neutral | 0 | 0.6 |
| Molina Healthcare (MOH) Stock Forecast and Price Target 2026 $MOH - MarketBeat | Molina Healthcare (MOH) Stock Forecast and Price Target 2026 $MOH MarketBeat | View source ↗ | MarketBeat | Oct 9, 2026 | neutral | 0 | 0.6 |
| Molina Healthcare (NYSE:MOH) Stock Forecast & Analyst Predictions - Simply Wall Street | Molina Healthcare (NYSE:MOH) Stock Forecast & Analyst Predictions Simply Wall Street | View source ↗ | Simply Wall Street | Oct 9, 2026 | neutral | 0 | 0.6 |
| Can Oscar Health Turn ACA Marketplace Growth Into Lasting Profits? | Oscar Health (OSCR) has surged 130% year-to-date driven by ACA marketplace expansion and plans to enter 150+ metro areas by 2027. However, the stock trades at a premium 4.94 price-to-book ratio versus the industry average of 2.64, and long-term profitability depends on disciplined underwriting and cost management rather than favorable policy conditions alone. Concentration risk from ACA exposure and potential subsidy policy changes pose headwinds. | View source ↗ | Zacks Investment Research | Oct 8, 2026 | bullish | 0.667 | 1 |
| Can Oscar Health Turn ACA Marketplace Growth Into Lasting Profits? | Oscar Health (OSCR) has surged 130% year-to-date driven by ACA marketplace expansion and plans to enter 150+ metro areas by 2027. However, the stock trades at a premium 4.94 price-to-book ratio versus the industry average of 2.64, and long-term profitability depends on disciplined underwriting and cost management rather than favorable policy conditions alone. Concentration risk from ACA exposure and potential subsidy policy changes pose headwinds. | View source ↗ | Zacks Investment Research | Oct 8, 2026 | bullish | 0.667 | 1 |
| UnitedHealth Gears Up for Q3 Earnings: Should Investors Buy the Stock? | UnitedHealth Group is expected to report Q3 2026 earnings on October 13, 2026, with projected EPS growth of 41.1% to $4.12 per share, despite a 1.6% revenue decline to $111.38 billion. The company faces headwinds from declining memberships across commercial, Medicare Advantage, and Medicaid segments, but improved medical cost management and operational restructuring are expected to support margin expansion. UnitedHealth trades below its historical valuation median at 17.15X forward earnings, positioning it for potential recovery. | View source ↗ | Zacks Investment Research | Oct 8, 2026 | bullish | 0.333 | 1 |
| UnitedHealth Gears Up for Q3 Earnings: Should Investors Buy the Stock? | UnitedHealth Group is expected to report Q3 2026 earnings on October 13, 2026, with projected EPS growth of 41.1% to $4.12 per share, despite a 1.6% revenue decline to $111.38 billion. The company faces headwinds from declining memberships across commercial, Medicare Advantage, and Medicaid segments, but improved medical cost management and operational restructuring are expected to support margin expansion. UnitedHealth trades below its historical valuation median at 17.15X forward earnings, positioning it for potential recovery. | View source ↗ | Zacks Investment Research | Oct 8, 2026 | bullish | 0.333 | 1 |
| UnitedHealth Gears Up for Q3 Earnings: Should Investors Buy the Stock? | UnitedHealth Group is expected to report Q3 2026 earnings on October 13, 2026, with projected EPS growth of 41.1% to $4.12 per share, despite a 1.6% revenue decline to $111.38 billion. The company faces headwinds from declining memberships across commercial, Medicare Advantage, and Medicaid segments, but improved medical cost management and operational restructuring are expected to support margin expansion. UnitedHealth trades below its historical valuation median at 17.15X forward earnings, positioning it for potential recovery. | View source ↗ | Zacks Investment Research | Oct 8, 2026 | bullish | 0.333 | 1 |
| 2 Reasons to Like MOH and 1 to Stay Skeptical - Yahoo Finance | 2 Reasons to Like MOH and 1 to Stay Skeptical Yahoo Finance | View source ↗ | Yahoo Finance | Oct 7, 2026 | neutral | 0 | 0.6 |
| Oscar Health Trading at a Premium: Why Should You Still Buy It? | Oscar Health (OSCR) trades at a premium valuation of 4.65x book value but has gained 142.5% year-to-date, driven by strong membership growth to 2.96 million, 70% revenue surge to $4.88 billion in Q2, and improved profitability. The company targets 20% revenue CAGR through 2027 and 5% operating margin next year, supported by its technology-driven platform and expansion into 150+ new metropolitan areas. Analysts maintain optimistic sentiment with upward earnings estimate revisions. | View source ↗ | Zacks Investment Research | Oct 5, 2026 | bullish | 0.333 | 1 |
| Should Value Investors Buy Molina Healthcare (MOH) Stock? - Yahoo Finance | Should Value Investors Buy Molina Healthcare (MOH) Stock? Yahoo Finance | View source ↗ | Yahoo Finance | Sep 28, 2026 | neutral | 0 | 0.6 |
| Molina Healthcare (MOH) Pulls Back Following Recent Weakness, Is The Stock Cheap? - Yahoo Finance | Molina Healthcare (MOH) Pulls Back Following Recent Weakness, Is The Stock Cheap? Yahoo Finance | View source ↗ | Yahoo Finance | Sep 22, 2026 | neutral | 0 | 0.6 |
| Molina Healthcare (MOH) Jumped 70.7% in Q2: Why the Stock Rally Was Enough to Sell - Yahoo Finance | Molina Healthcare (MOH) Jumped 70.7% in Q2: Why the Stock Rally Was Enough to Sell Yahoo Finance | View source ↗ | Yahoo Finance | Sep 21, 2026 | neutral | 0 | 0.6 |
| Molina Healthcare (MOH) Draws Fresh Attention, Is The Stock Still A Bargain? - Yahoo Finance | Molina Healthcare (MOH) Draws Fresh Attention, Is The Stock Still A Bargain? Yahoo Finance | View source ↗ | Yahoo Finance | Aug 26, 2026 | neutral | 0 | 0.6 |
| Molina Healthcare (MOH) Stock Looks Like A Bargain After Strong Q1 Results - Yahoo Finance | Molina Healthcare (MOH) Stock Looks Like A Bargain After Strong Q1 Results Yahoo Finance | View source ↗ | Yahoo Finance | Aug 25, 2026 | neutral | 0 | 0.6 |
| MOLINA HEALTHCARE ($MOH) Releases Q2 2026 Earnings | MOH Stock News - Quiver Quantitative | MOLINA HEALTHCARE ($MOH) Releases Q2 2026 Earnings | MOH Stock News Quiver Quantitative | View source ↗ | Quiver Quantitative | Jul 22, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.